Inside the NHS: A Quiet Revolt Against Palantir's Data Platform

A new report reveals a significant hurdle for England's National Health Service: its own staff are choosing not to use a flagship data system. NHS England awarded Palantir Technologies a contract worth up to £330 million to build the Federated Data Platform (FDP), intended to unify patient information across hospitals to manage waiting lists and resources. Yet, according to the Financial Times, a number of clinicians and administrators are refusing to engage with it.

The core issue is the vendor. Employees cite Palantir's established work with U.S. intelligence and defense agencies, including Immigration and Customs Enforcement, as a source of profound discomfort. For them, the question isn't solely about the platform's technical safeguards, but whether a company with this background should process sensitive medical records at all. This passive resistance presents a unique operational challenge, as the system's value depends on widespread adoption.

NHS England and Palantir assert that strict data governance keeps patient information under NHS control and that the platform cannot access identifiable records without permission. However, critics like Dr. Jeni Tennison of Connected by Data argue the patient consent model lacks transparency, leaving most unaware of the platform's existence or Palantir's involvement.

The situation places the government in a difficult position. The new Labour administration supports digital modernization but relies on a workforce expressing deep ethical reservations. While Palantir has launched public relations efforts to reshape its image in the UK, staff objections highlight a fundamental tension: can a publicly-traded defense technology firm be a long-term steward for a nation's health data? The effectiveness of the £330 million system may now hinge on answering that question.

Source: Webpronews